Axonal distribution of mitochondria maintains neuronal autophagy during aging via eIF2β
Figures
Knockdown of milton or Miro causes protein accumulation in the axon.
(A) Schematic representation of the mitochondrial transport machinery. Knockdown of milton, an adapter protein for mitochondrial transport, depletes mitochondria in the axon. (B, C) Ubiquitinated proteins in brains with neuronal knockdown of milton or Miro. Brains dissected at 14-day-old (B) or 30-day-old (C) were immunostained with an antibody against ubiquitin. Firefly luciferase RNAi was used as a control. Representative images (left) and quantitation of the number of ubiquitin-positive puncta (right) are shown. Scale bars of hemibrains, 100 µm, Scale bars of high magnifications, 10 µm. Means ± SE, n=8. N.S., p>0.05; ***p<0.005 (one-way analysis of variance (ANOVA) followed by Tukey’s honestly significant difference (HSD) post hoc test). (D) Cross-sections in the lamina and in the retina were used to analyze the ultrastructure of synapses and cell bodies, respectively. milton RNAi was expressed in the retina and neurons via a combination of GAL4 drivers, a pan-retinal gmr-GAL4 and pan-neuronal elav-GAL4. (E) Quantitation of the number of mitochondria in a presynaptic terminal from transmission electron micrographs. 180 presynaptic terminals from cross-sections of the lamina from three brains were analyzed. ***p<0.005 (Chi-square test). (F, G) Presynaptic terminals of photoreceptor neurons of control and milton knockdown flies. Photoreceptor neurons are highlighted in blue. Swollen presynaptic terminals (asterisks in F), characterized by the enlargement and higher circularity, were found more frequently in milton knockdown neurons. Arrowheads indicate presynaptic terminals with dense materials. Scale bars, 2 µm. Representative images (Left) and quantitation (Right) are shown. 918–1118 from three heads were quantified for the percentage of swollen presynaptic terminals, and 180 presynaptic terminals from three heads were quantified for the size of presynaptic terminals. Mean ± SE, **p<0.01, ***p<0.005 (Student’s t-test). (G) Dense materials (arrowheads in G) in the presynaptic terminals of milton knockdown neurons. Scale bars, 2 µm. The ratio of presynaptic terminals containing dense materials was quantified from 918 to 1118 presynaptic terminals from three heads. Mean ± SE, ***p<0.005 (Student’s t-test). (H) Cell bodies of photoreceptor neurons of control and milton knockdown flies. Scale bars, 2 µm. Flies were 27-day-old.
Ubiquitinated proteins in brains with neuronal knockdown of milton at 1-day-old.
Brains dissected at 1-day-old were immunostained with an antibody against ubiquitin. Representative images (left) and quantitation of the number of ubiquitin-positive puncta (right) are shown. Scale bars of hemibrains, 100 µm, Means ± SE, n=8. N.S., p>0.05 (Student’s t-test).
milton knockdown impairs protein degradation pathways.
(A, B) Western blotting of head extracts of control and milton knockdown flies with antibodies against LC3 (A) and Ref2P, the fly homolog of mammalian p62 (B). For the analyses of p62 levels, heads were extracted with 1% Triton X-100 or 2% SDS (B). Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Actin was used as a loading control. Means ± SE, n=6 (LC3), n=3 (p62). (C) Proteasome activity in head extracts of control and milton knockdown flies was measured by hydrolysis of Suc-LLVY-AMC at 14-day-old. Means ± SE, n=3. (D, E) Western blotting of head extracts of 30-day-old control and milton knockdown flies. Blotting was performed with anti-LC3 (D) and anti-p62 (E) antibodies. Representative blots (left) and quantitation (right) are shown. Actin was used as a loading control. Means ± SE, n=6 (LC3), n=3 (p62). (F) Proteasome activity in head extracts of 30-day-old control and milton knockdown flies. Means ± SE, n=3. N.S., p>0.05; *p<0.05; **p<0.01; ***p<0.005 (Student’s t-test).
-
Figure 2—source data 1
PDF file containing original western blots for Figure 2, indicating the relevant bands.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig2-data1-v1.zip
-
Figure 2—source data 2
Original files for western blot analysis displayed in Figure 2.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig2-data2-v1.zip
ATP deprivation does not impair autophagy.
(A–C) ATP levels in brain extracts of control and milton knockdown flies (A) and control and Pfk knockdown flies (B) and comparison of the effects of milton knockdown and Pfk knockdown on ATP levels (C). Flies were 14-day-old. Means ± SE, n=3. (D, E) Western blotting of head extracts of flies with neuronal expression of control or Pfk RNAi. Blotting was performed with anti-LC3 (D) and anti-p62 (E) antibodies. For analyses of p62 levels, heads were extracted with 1% Triton X-100 or 2% SDS. Representative blots (left) and quantitation (right) are shown. Actin was used as a loading control. Means ± SE, n=6 (LC3), n=3 (p62). (F) Proteasome activity in head lysates of flies with neuronal expression of control or Pfk RNAi was measured by hydrolysis of Suc-LLVY-AMC. Means ± SE, n=3. N.S., p>0.05; *p<0.05; **p<0.01; ***p<0.005 (Student’s t-test). Flies were 14 days old.
-
Figure 3—source data 1
PDF file containing original western blots for Figure 3 indicating the relevant bands.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig3-data1-v1.zip
-
Figure 3—source data 2
Original files for western blot analysis displayed in Figure 3.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig3-data2-v1.zip
milton knockdown upregulates eIF2β in young flies.
(A) Timing of proteome analysis and phenotypes observed in milton knockdown flies. (B) and (C) Volcano plots of the log2 abundance ratio (x-axis) against the -log10 p-value (y-axis) of proteins at 7 days old (B) and 21 days old (C). (D) eIF2 subunit protein levels from proteome analysis of milton knockdown flies compared to those of control flies. (E) Western blotting of head extracts of flies expressing control or milton RNAi in neurons with an anti-eIF2β antibody. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n=6. (F) eIF2β mRNA levels quantified by qRT-PCR. Means ± SE, n=4. (G) Western blotting of head extracts of wild-type flies with an anti-eIF2β antibody. Flies were 7-, 21-, 35-, 49-, and 63-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n=3, *p<0.05 (one-way analysis of variance (ANOVA) followed by Dunnett’s multiple comparison test).
-
Figure 4—source data 1
PDF file containing original western blots for Figure 4, indicating the relevant bands.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig4-data1-v1.zip
-
Figure 4—source data 2
Original files for western blot analysis displayed in Figure 4.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig4-data2-v1.zip
milton knockdown decreases phosphorylation of eIF2α.
(A, B) Western blotting of head extracts with anti-eIF2α (A) and anti-p-eIF2α (B) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n=6. (C) A schematic representation of the axon (Lobe tips), the cell body region (Kenyon cells), and dendritic region (Calyxes) in the fly brain. Scale bars, 100 µm. (D, E) Immunostaining with anti-eIF2α and anti-p-eIF2α antibodies. The mushroom body was identified by expression of mito-GFP. Scale bars, 20 µm. The signal intensities of eIF2α and p-eIF2α in axons, dendrites, and cell bodies were quantified and are shown as ratios relative to the control. Means ± SE, n =12. N.S., p>0.05; *p<0.05; **p<0.01; ***p<0.005 (Student’s t-test).
-
Figure 5—source data 1
PDF file containing original western blots for Figure 5 indicating the relevant bands.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig5-data1-v1.zip
-
Figure 5—source data 2
Original files for western blot analysis displayed in Figure 5.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig5-data2-v1.zip
milton knockdown suppressed global translation.
(A) Representative polysome traces of head lysates of control and milton knockdown flies. (B) Quantitation of polysome fraction. The relative ratio of area under the curve (AUC) of polysome fractions (sedimentation 28–50%). Means ± SE, n=3. ***p<0.005 (Student’s t-test) (C) Western blotting of head lysates of control and milton knockdown flies fed puromycin alone or puromycin and cycloheximide (CHX) with an anti-puromycin antibody. Flies were 14-day-old. Actin was used as a loading control. Representative blots (left) and quantitation (right) are shown. Means ± SE, n=3. Student’s t-test.
-
Figure 6—source data 1
PDF file containing original western blots for Figure 6, indicating the relevant bands.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig6-data1-v1.zip
-
Figure 6—source data 2
Original files for western blot analysis displayed in Figure 6.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig6-data2-v1.zip
eIF2β upregulation impairs autophagy and decreases locomotor function.
(A) eIF2β mRNA levels in head extracts of flies with UAS-eIF2β driven by elav-Gal4 (eIF2β OE) or UAS-GFP driven by elav-Gal4 (control) were quantified by qRT-PCR. Flies were 2-day-old. Means ± SE, n=4. (B, C) Western blotting of head extracts with anti-LC3 (B) and anti-p62 (C) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin and actin were used as loading controls. Means ± SE, n=3 (p62), n=5 (LC3). (D, E) Western blotting of head extracts with anti-eIF2α (D) and anti-p-eIF2α (E) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n=6. (F) Climbing assay revealed early-onset of age-dependent locomotor defects in eIF2β-overexpressing flies. Means ± SE, n=5. N.S., p>0.05; ***p<0.005 (Student’s t-test).
-
Figure 7—source data 1
PDF file containing original western blots for Figure 7 indicating the relevant bands.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig7-data1-v1.zip
-
Figure 7—source data 2
Original files for western blot analysis displayed in Figure 7.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig7-data2-v1.zip
Histology analysis of fly heads with eIF2β overexpression.
The morphology of the eye with eIF2β overexpression. The dotted lines indicate the retina. Vacuoles are indicated by arrows. Representative images (left) and quantification of vacuole area (right). The flies were 40-day-old. Means ± SE, n=5–13 N.S., p>0.05 (Student’s t-test).
Lowering eIF2β rescues autophagic impairment and locomotor dysfunction induced by milton knockdown.
(A) eIF2β mRNA levels with one disrupted copy of the eIF2β gene (eIF2βSAstopDsRed/+ [eIF2β -/+]). Head extracts of flies 2–3 day-old were analyzed by qRT-PCR. Means ± SE, n=3. (B, C) Western blotting of head extracts of flies with neuronal expression of milton RNAi with or without eIF2β heterozygosity with anti-LC3 (B) and anti-p62 (C) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Actin was used as a loading control. Means ± SE, n=5 (LC3), n=3 (p62). (D) The climbing ability of 20-day-old flies expressing milton RNAi with or without eIF2β heterozygosity. Means ± SE, n=15. N.S., p>0.05; *p<0.05; ***p<0.005 (Student’s t-test).
-
Figure 8—source data 1
PDF file containing original western blots for Figure 8, indicating the relevant bands.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig8-data1-v1.zip
-
Figure 8—source data 2
Original files for western blot analysis displayed in Figure 8.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig8-data2-v1.zip
Lowering the eIF2β level does not affect the levels of eIF2α and p-eIF2α.
(A, B) Blotting was performed with anti-eIF2α (A) and anti-p-eIF2α (B) antibodies. Flies were 14-day-old. Representative blots (left) and quantitation (right) are shown. Tubulin was used as a loading control. Means ± SE, n=6. (C) eIF2β gene disruption does not affect the knockdown efficiency of milton. milton mRNA levels in head extracts were quantified by qRT-PCR. Flies were 2-day-old. Means ± SE, n=3. N.S., p>0.05; *p<0.05 (Student’s t-test).
-
Figure 8—figure supplement 1—source data 1
PDF file containing original western blots for Figure 8—figure supplement 1 indicating the relevant bands.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig8-figsupp1-data1-v1.zip
-
Figure 8—figure supplement 1—source data 2
Original files for western blot analysis displayed in Figure 8—figure supplement 1.
- https://cdn.elifesciences.org/articles/95576/elife-95576-fig8-figsupp1-data2-v1.zip
The mitochondria-eIF2β axis in the axon maintains neuronal proteostasis during aging.
Aging is associated with a reduction in axonal transport of mitochondria. Our results suggest that the loss of axonal mitochondria leads to an increase in eIF2β, while the upregulation of eIF2β decreases autophagy-mediated protein degradation and promotes aging.
Tables
Differentially expressed proteins in milton RNAi fly brains compared to control at 7 day-old detected by proteome analysis.
| 7-day-old | |||
|---|---|---|---|
| Accession* | Name | Abundance ratio:(7 days, milton KD)/ (7 days, control) | Abundance ratio p-value: (7 days, milton KD) / (7 days, control) |
| Q9V751 | Attacin-B | 100 | 1E-17 |
| Q04448 | Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial | 100 | 1E-17 |
| P22700 | Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type | 100 | 1E-17 |
| Q9V558 | Cytochrome P450 4p1 | 100 | 1E-17 |
| P10552 | FMRFamide-related peptides | 100 | 1E-17 |
| P05661-19 | Isoform F of Myosin heavy chain, muscle | 100 | 1E-17 |
| Q9VE01 | Probable cytochrome P450 12a5, mitochondrial | 100 | 1E-17 |
| Q7KIN0 | Toll-like receptor 7 | 100 | 1E-17 |
| Q8MKN0 | Ubiquinone biosynthesis protein COQ9, mitochondrial | 100 | 1E-17 |
| Q9VJG0 | Xaa-Pro aminopeptidase ApepP | 100 | 1E-17 |
| Q9V8F5 | Bomanin Bicipital 1 | 4.908 | 1E-17 |
| P07701 | Salivary glue protein Sgs-5 | 2.843 | 1.99252E-09 |
| O76902 | Pleckstrin homology domain-containing family F member 1 homolog | 2.836 | 2.22045E-16 |
| P81641 | Alpha-amylase B | 2.684 | 7.44847E-09 |
| P19351-4 | Isoform 4 of Troponin T, skeletal muscle | 2.66 | 6.65563E-11 |
| Q9VTJ8 | Mitochondrial import inner membrane translocase subunit TIM14 | 2.61 | 3.54205E-07 |
| P41375 | Eukaryotic translation initiation factor 2 subunit 2 | 2.465 | 3.38486E-09 |
| Q9VYB0 | Selenoprotein BthD | 2.462 | 2.25579E-08 |
| B7Z0W9 | Proton channel OtopLc | 2.382 | 1.71741E-06 |
| Q9VLR5 | RNA polymerase II transcriptional coactivator | 2.245 | 6.70245E-09 |
| Q8IN44 | Protein Turandot A | 2.127 | 8.38662E-13 |
| P27779 | Pupal cuticle protein Edg-78E | 2.113 | 1.00215E-08 |
| Q9W1X8 | Probable GDP-L-fucose synthase | 0.496 | 2.12601E-08 |
| P55035 | 26 S proteasome non-ATPase regulatory subunit 4 | 0.487 | 5.50158E-11 |
| Q9VHN6 | 39 S ribosomal protein L19, mitochondrial | 0.487 | 0.000551337 |
| Q9VPD2 | Cytosolic Fe-S cluster assembly factor NUBP2 homolog | 0.46 | 6.34514E-05 |
| Q9VHD3 | Probable maleylacetoacetate isomerase 1 | 0.432 | 4.50956E-06 |
| Q94529 | Probable pseudouridine-5'-phosphatase | 0.416 | 1.08802E-14 |
| Q27606 | Cytochrome P450 4e2 | 0.398 | 4.13128E-10 |
| Q24388 | Larval serum protein 2 | 0.378 | 1.33227E-14 |
| Q9VKH6 | Lysosomal thioesterase PPT2 homolog | 0.369 | 2.05225E-06 |
| Q24114 | Division abnormally delayed protein | 0.307 | 2.24406E-09 |
| Q95NH6 | Attacin-C | 0.01 | 1E-17 |
| P29993 | Inositol 1,4,5-trisphosphate receptor | 0.01 | 1E-17 |
| Q94526 | Open rectifier potassium channel protein 1 | 0.01 | 1E-17 |
| Q9Y115 | UNC93-like protein | 0.01 | 1E-17 |
| 21-day-old | |||
| Accession* | Name | Abundance ratio:(21 days, milton KD) /(21 days, control) | Abundance ratio p-value:(21 days, milton KD) /(21 days, control) |
| Q10714 | Angiotensin-converting enzyme | 100 | 1E-17 |
| C0HKQ8 | Cecropin-A2 | 100 | 1E-17 |
| Q9V558 | Cytochrome P450 4p1 | 100 | 1E-17 |
| P51592 | E3 ubiquitin-protein ligase hyd | 100 | 1E-17 |
| Q9VMJ7 | Lysine-specific demethylase lid | 100 | 1E-17 |
| Q9VXP4 | Platelet-activating factor acetylhydrolase IB subunit beta homolog | 100 | 1E-17 |
| Q9VY28 | Probable 28 S ribosomal protein S25, mitochondrial | 100 | 1E-17 |
| Q9W391 | Probable phosphorylase b kinase regulatory subunit alpha | 100 | 1E-17 |
| Q9VUQ5 | Protein argonaute-2 | 100 | 1E-17 |
| P54359 | Septin-2 | 100 | 1E-17 |
| P24492 | Diptericin A | 15.716 | 1E-17 |
| Q9VVY3 | Glycogen-binding subunit 76 A | 8.986 | 1E-17 |
| Q70PY2 | Peptidoglycan-recognition protein SB1 | 6.669 | 1E-17 |
| Q9W0M1 | Centrosomal protein cep290 | 6.526 | 1E-17 |
| P81641 | Alpha-amylase B | 5.722 | 1E-17 |
| P45884 | Attacin-A | 4.997 | 1E-17 |
| C0HL66 | Histone H3.3A | 4.778 | 1E-17 |
| P26675 | Protein son of sevenless | 4.696 | 1E-17 |
| P02515 | Heat shock protein 22 | 4.69 | 1E-17 |
| Q95NH6 | Attacin-C | 4.35 | 1E-17 |
| P17971-1 | Isoform A of Potassium voltage-gated channel protein Shal | 4.195 | 1E-17 |
| Q7K1U0 | Activity-regulated cytoskeleton associated protein 1 | 3.271 | 1E-17 |
| P14199 | Protein ref(2)P | 3.014 | 1E-17 |
| Q9VU02 | Probable small nuclear ribonucleoprotein Sm D1 | 2.43 | 4.91607E-13 |
| Q9VD44 | Poly(A) RNA polymerase gld-2 homolog A | 2.268 | 2.6084E-11 |
| Q9V8F5 | Bomanin Bicipital 1 | 2.24 | 5.16671E-11 |
| P22979 | Heat shock protein 67B3 | 2.223 | 7.90048E-11 |
| P27779 | Pupal cuticle protein Edg-78E | 2.192 | 1.65944E-10 |
| Q9NBK5 | Serine/threonine-protein kinase tricornered | 2.059 | 4.15071E-09 |
| Q8MLZ7 | Chitinase-like protein Idgf3 | 2.055 | 4.61182E-09 |
| Q9V751 | Attacin-B | 2.038 | 6.79416E-09 |
| Q9V8M5 | Probable 3-hydroxyisobutyrate dehydrogenase, mitochondrial | 0.492 | 7.42952E-09 |
| P84345 | ATP synthase protein 8 | 0.421 | 1.809E-12 |
| P33438 | Glutactin | 0.414 | 6.13731E-13 |
| Q8IN44 | Protein Turandot A | 0.218 | 1E-17 |
| Q8IN43 | Protein Turandot C | 0.195 | 1E-17 |
| Q9VFI9 | cGMP-specific 3',5'-cyclic phosphodiesterase | 0.01 | 1E-17 |
| Q94526 | Open rectifier potassium channel protein 1 | 0.01 | 1E-17 |
| Q9VHD3 | Probable maleylacetoacetate isomerase 1 | 0.01 | 1E-17 |
| Q9W0A0 | Protein draper | 0.01 | 1E-17 |
| A1Z7T0 | Serine/threonine-protein kinase N | 0.01 | 1E-17 |
-
*
UniProt accession number.
Molecule networks based on “Interaction search” of KeyMolnet.
| 7-day-old | |||||
|---|---|---|---|---|---|
| Rank | Name | Score | Score (p)* | Score (v)† | Score (c)‡ |
| 1 | Autophagy-related protein signaling pathway | 50.394 | 6.76E-16 | 0.159 | 0.11 |
| 2 | Calcium signaling pathway | 47.583 | 4.75E-15 | 0.146 | 0.117 |
| 3 | Transcriptional regulation by SMAD | 44.012 | 5.64E-14 | 0.146 | 0.095 |
| 4 | GABA signaling pathway | 40.706 | 5.58E-13 | 0.122 | 0.123 |
| 5 | estrogen signaling pathway | 37.507 | 5.12E-12 | 0.11 | 0.13 |
| 6 | Sirtuin signaling pathway | 36.87 | 7.96E-12 | 0.122 | 0.095 |
| 7 | Transcriptional regulation by AP-1 | 34.874 | 3.18E-11 | 0.11 | 0.107 |
| 8 | Arrestin signaling pathway | 32.84 | 1.30E-10 | 0.11 | 0.092 |
| 9 | G protein (Gq/11) signaling pathway | 30.889 | 5.03E-10 | 0.085 | 0.149 |
| 10 | Kainate receptor signaling pathway | 30.049 | 9.00E-10 | 0.073 | 0.214 |
| 11 | Transcriptional regulation by C/EBP | 29.5 | 1.32E-09 | 0.098 | 0.093 |
| 12 | Calpain signaling pathway | 28.597 | 2.46E-09 | 0.11 | 0.066 |
| 13 | Phospholipase D signaling pathway | 28.344 | 2.94E-09 | 0.098 | 0.084 |
| 14 | HSP90 signaling pathway | 27.188 | 6.54E-09 | 0.085 | 0.104 |
| 14 | CYP family | 27.188 | 6.54E-09 | 0.085 | 0.104 |
| 16 | Kir3 channel signaling pathway | 26.495 | 1.06E-08 | 0.061 | 0.25 |
| 17 | Estrogen biosynthesis | 26.107 | 1.38E-08 | 0.061 | 0.238 |
| 18 | CaSR signaling pathway | 25.39 | 2.27E-08 | 0.061 | 0.217 |
| 19 | PI3K signaling pathway | 24.927 | 3.14E-08 | 0.073 | 0.122 |
| 20 | PAF receptor signaling pathway | 24.555 | 4.06E-08 | 0.049 | 0.4 |
| 21 | Transcriptional regulation by PPARa | 24.398 | 4.52E-08 | 0.073 | 0.115 |
| 21 | BTK signaling pathway | 24.398 | 4.52E-08 | 0.073 | 0.115 |
| 23 | Transcriptional regulation by STAT | 24.076 | 5.66E-08 | 0.085 | 0.077 |
| 24 | G protein (Gi/o) signaling pathway | 24.063 | 5.71E-08 | 0.073 | 0.111 |
| 25 | PARP signaling pathway | 23.742 | 7.13E-08 | 0.073 | 0.107 |
| 25 | mGluR signaling pathway | 23.742 | 7.13E-08 | 0.073 | 0.107 |
| 27 | Free fatty acid signaling pathway | 23.433 | 8.83E-08 | 0.073 | 0.103 |
| 28 | Kir channel signaling pathway | 23.338 | 9.43E-08 | 0.061 | 0.167 |
| 29 | Oxytocin signaling pathway | 23.327 | 9.51E-08 | 0.049 | 0.333 |
| 30 | Transcriptional regulation by MEF2 | 22.99 | 1.20E-07 | 0.073 | 0.098 |
| 31 | S100 family signaling pathway | 22.434 | 1.77E-07 | 0.073 | 0.092 |
| 32 | Transcriptional regulation by FOXO | 22.301 | 1.94E-07 | 0.073 | 0.091 |
| 33 | P2Y signaling pathway | 22.172 | 2.12E-07 | 0.061 | 0.143 |
| 34 | Transcriptional regulation by SRF | 21.174 | 4.23E-07 | 0.061 | 0.125 |
| 34 | ATF4/ATF6/IRE1 signaling pathway | 21.174 | 4.23E-07 | 0.061 | 0.125 |
| 36 | Chemerin signaling pathway | 21.082 | 4.50E-07 | 0.049 | 0.235 |
| 36 | Vasopressin signaling pathway | 21.082 | 4.50E-07 | 0.049 | 0.235 |
| 38 | Serotonin signaling pathway | 20.854 | 5.28E-07 | 0.073 | 0.077 |
| 39 | Transcriptional regulation by HIF | 20.834 | 5.35E-07 | 0.098 | 0.043 |
| 40 | Leukotriene receptor signaling pathway | 20.724 | 5.78E-07 | 0.049 | 0.222 |
| 40 | CART signaling pathway | 20.724 | 5.78E-07 | 0.049 | 0.222 |
| 42 | MAPK signaling pathway | 20.693 | 5.90E-07 | 0.085 | 0.055 |
| 43 | Transcriptional regulation by RB/E2F | 20.543 | 6.55E-07 | 0.098 | 0.042 |
| 44 | NAD metabolism | 20.468 | 6.89E-07 | 0.061 | 0.114 |
| 45 | ERK signaling pathway | 20.425 | 7.11E-07 | 0.073 | 0.073 |
| 46 | Adenylyl Cyclase signaling pathway | 20.303 | 7.73E-07 | 0.061 | 0.111 |
| 47 | Bile acid signaling pathway | 20.141 | 8.65E-07 | 0.061 | 0.109 |
| 21-day-old | |||||
| Rank | Name | Score | Score (p)* | Score (v)† | Score (c)‡ |
| 1 | Histone demethylation | 84.198 | 4.51E-26 | 0.102 | 0.425 |
| 2 | CDK inhibitor signaling pathway | 56.497 | 9.83E-18 | 0.078 | 0.295 |
| 3 | Transcriptional regulation by RB/E2F | 46.598 | 9.39E-15 | 0.108 | 0.095 |
| 4 | Mst(Hippo) signaling pathway | 46.343 | 1.12E-14 | 0.09 | 0.133 |
| 5 | Transcriptional regulation by androgen receptor | 46.078 | 1.35E-14 | 0.078 | 0.178 |
| 6 | p160 SRC signaling pathway | 45.809 | 1.62E-14 | 0.078 | 0.176 |
| 7 | Transcriptional regulation by SMAD | 43.961 | 5.84E-14 | 0.09 | 0.119 |
| 8 | Autophagy-related protein signaling pathway | 41.063 | 4.35E-13 | 0.084 | 0.119 |
| 9 | Transcriptional regulation by HIF | 39.527 | 1.26E-12 | 0.096 | 0.086 |
| 10 | Nucleophosmin signaling pathway | 38.417 | 2.72E-12 | 0.054 | 0.273 |
| 11 | HSP90 signaling pathway | 37.887 | 3.93E-12 | 0.066 | 0.164 |
| 12 | PAF metabolism | 37.562 | 4.93E-12 | 0.042 | 0.5 |
| 13 | Transcriptional regulation by STAT | 37.276 | 6.01E-12 | 0.072 | 0.132 |
| 14 | Bcl-2 family signaling pathway | 36.157 | 1.31E-11 | 0.072 | 0.124 |
| 15 | Sirtuin signaling pathway | 34.782 | 3.39E-11 | 0.072 | 0.114 |
| 16 | Transcriptional regulation by C/EBP | 33.819 | 6.60E-11 | 0.066 | 0.128 |
| 17 | PIN1 signaling pathway | 33.172 | 1.03E-10 | 0.06 | 0.149 |
| 18 | RSK signaling pathway | 30.566 | 6.29E-10 | 0.06 | 0.125 |
| 19 | Transcriptional regulation by High mobility group protein | 29.873 | 1.02E-09 | 0.054 | 0.148 |
| 20 | BET family signaling pathway | 29.656 | 1.18E-09 | 0.054 | 0.145 |
| 21 | Transcriptional regulation by Myc | 28.838 | 2.08E-09 | 0.066 | 0.093 |
| 22 | Transcriptional regulation by FOXO | 28.827 | 2.10E-09 | 0.054 | 0.136 |
| 23 | PSD-95 family signaling pathway | 26.154 | 1.34E-08 | 0.048 | 0.14 |
| 24 | AKT signaling pathway | 25.169 | 2.65E-08 | 0.048 | 0.129 |
| 25 | Arginine methylation | 24.799 | 3.43E-08 | 0.048 | 0.125 |
| 26 | gp130 signaling pathway | 24.25 | 5.01E-08 | 0.054 | 0.096 |
| 27 | Transcriptional regulation by CREB | 23.858 | 6.58E-08 | 0.066 | 0.067 |
| 28 | Gene regulation by microRNAs (metastasis) | 23.852 | 6.60E-08 | 0.054 | 0.093 |
| 29 | HDAC signaling pathway | 23.536 | 8.22E-08 | 0.036 | 0.207 |
| 30 | Calpain signaling pathway | 23.092 | 1.12E-07 | 0.06 | 0.074 |
| 31 | Transcriptional regulation by IRF | 22.738 | 1.43E-07 | 0.054 | 0.085 |
| 32 | 2-Oxoglutarate signaling pathway | 22.673 | 1.50E-07 | 0.048 | 0.104 |
| 32 | 14-3-3 signaling pathway | 22.673 | 1.50E-07 | 0.048 | 0.104 |
| 34 | Transcriptional regulation by POU domain factor | 22.601 | 1.57E-07 | 0.06 | 0.071 |
| 35 | Transcriptional regulation by BLIMP-1 | 22.474 | 1.72E-07 | 0.042 | 0.132 |
| 36 | Gene regulation by microRNAs (metabolism) | 22.39 | 1.82E-07 | 0.054 | 0.083 |
| 37 | Fatty acid beta oxidation | 22.096 | 2.23E-07 | 0.042 | 0.127 |
| 38 | Transcriptional regulation by RXR | 22.08 | 2.26E-07 | 0.036 | 0.176 |
| 39 | ERK signaling pathway | 21.96 | 2.45E-07 | 0.048 | 0.098 |
| 40 | PARP signaling pathway | 21.913 | 2.53E-07 | 0.042 | 0.125 |
| 41 | Transcriptional regulation by VDR | 21.618 | 3.11E-07 | 0.054 | 0.078 |
| 42 | Transcriptional regulation by p53 | 21.168 | 4.24E-07 | 0.072 | 0.05 |
| 43 | Acetylcholine metabolism | 21.152 | 4.29E-07 | 0.024 | 0.444 |
| 44 | Gene regulation by microRNAs (embryonic stem cells) | 21.08 | 4.51E-07 | 0.036 | 0.158 |
| 45 | mTOR signaling pathway | 21.048 | 4.61E-07 | 0.042 | 0.115 |
| 46 | Gene regulation by microRNAs (cancer) | 21.04 | 4.64E-07 | 0.048 | 0.09 |
| 47 | Transcriptional regulation by Ets-1/2 | 20.724 | 5.77E-07 | 0.042 | 0.111 |
| 48 | MAPK signaling pathway | 20.411 | 7.18E-07 | 0.054 | 0.07 |
| 49 | Gene regulation by microRNAs (cell cycle) | 20.404 | 7.21E-07 | 0.036 | 0.146 |
| 50 | Transcriptional regulation by p73 | 20.259 | 7.97E-07 | 0.042 | 0.106 |
-
*
Score(p) indicates p-value of the pathway.
-
†
Score(v) indicates the ratio of ‘Count’ to total molecules associated with the loaded list.
-
‡
Score(c) indicates the ratio of ‘Count’ to total molecules contained in the pathway.
| Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
|---|---|---|---|---|
| Strain, strain background (Drosophila) | UAS-milton RNAi | Vienna Drosophila Resource Center (VDRC) | VDRC:v41508, FLYB:FBst0464139 | |
| Strain, strain background (Drosophila) | UAS-Miro RNAi | Iijima-Ando et al., 2012 | ||
| Strain, strain background (Drosophila) | UAS-luciferase RNAi | Iijima-Ando et al., 2012 | ||
| Strain, strain background (Drosophila) | UAS-Pfk RNAi | Bloomington Drosophila Stock Center | BDSC:36782, FLYB:FBti0146432 | |
| Strain, strain background (Drosophila) | UAS-luciferase RNAi | Bloomington Drosophila Stock Center | BDSC:31603, FLYB:FBti0130444 | |
| strain, strain background (Drosophila) | UAS-eIF2β | Bloomington Drosophila Stock Center | BDSC:17425, FLYB:FBti0038792 | |
| Strain, strain background (Drosophila) | UAS-GFP | Bloomington Drosophila Stock Center | BDSC:1521, FLYB:FBti0003040 | |
| Strain, strain background (Drosophila) | eIF2β[PBac{SAstopDsRed} LL07719] | KYOTO Drosophila Stock Center (DGRC) | DGRC:142114, FLYB:FBgn0004926 | |
| Strain, strain background (Drosophila) | w1118 | Vienna Drosophila Resource Center (VDRC) | VDRC:60000 | |
| Strain, strain background (Drosophila) | UAS-mitoGFP | M. Saxton, University of California, Santa Cruz | ||
| Strain, strain background (Drosophila) | elav-GAL4 | Bloomington Drosophila Stock Center | BDSC:458, FLYB:FBti0002575 | |
| Strain, strain background (Drosophila) | GMR-gal4 | Bloomington Drosophila Stock Center | BDSC:1104, FLYB:FBti0002994 | |
| Antibody | anti-ubiquitin antibody Ubi-1 | Thermo Fisher | Cat#:13–1600, RRID:AB_2533002 | IHC:1:50 |
| Antibody | anti-LC3 antibody Atg8 | Merck Millipore | Cat#:ABC974, RRID:AB_2939040 | WB:1:1000 |
| Antibody | anti-p62 antibody Ref2P | Abcam | Cat#:ab178440, RRID:AB_2938801 | WB:1:750 |
| Antibody | anti-eIF2α | Abcam | Cat#:ab26197, RRID:AB_2096478 | IHC:1:50 |
| Antibody | anti-p-eIF2α | Cell signaling | Cat#:3398 S, RRID:AB_2096481 | IHC:1:50 |
| Antibody | anti-Drosophila eIF2β | This paper | WB:1:1500 | |
| Antibody | anti-puromycin | Enzo | Cat#:CAC-CAC-PEN-MA001, RRID:AB_2620162 | WB:1:1000 |
| Antibody | anti-actin | Sigma | Cat#:A2066, RRID:AB_476693 | WB:1:3000 |
| Antibody | anti-β tubulin | Sigma | Cat#:T9026, RRID:AB_477593 | WB:1:10000 |
| Antibody | peroxidase-conjugated goat anti-mouse IgG antibody | Dako | Cat#:P0447, RRID:AB_2617137 | WB:1:2000 |
| Antibody | peroxidase-conjugated pig anti-rabbit IgG antibody | Dako | Cat#:P0399, RRID:AB_2617141 | WB:1:2000 |
| Commercial Assay or Kit | 20 S Proteasome Substrate (SUC-LLVY-AMC) | Cayman | Cat#:10011095 | |
| Commercial Assay or Kit | ATP Determination Kit | Invitrogen | Cat#:A22066 |
Additional files
-
Supplementary file 1
Excel file containing a list of proteins detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
- https://cdn.elifesciences.org/articles/95576/elife-95576-supp1-v1.xlsx
-
Supplementary file 2
Excel file containing a list of fly genotypes used in this study.
- https://cdn.elifesciences.org/articles/95576/elife-95576-supp2-v1.xlsx
-
MDAR checklist
- https://cdn.elifesciences.org/articles/95576/elife-95576-mdarchecklist1-v1.docx